TY  - JOUR
AU  - Rodriguez-Peralvarez, Manuel
AU  - Rico-Juri, Jose M
AU  - Tsochatzis, Emmanuel
AU  - Burra, Patrizia
AU  - De la Mata, Manuel
AU  - Lerut, Jan
PY  - 2015
DO  - 10.1111/tri.12737
UR  - http://hdl.handle.net/10668/9688
T2  - Transplant international : official journal of the European Society for Organ Transplantation
AB  - Biopsy-proven acute cellular rejection (ACR) is the primary efficacy endpoint in most randomized trials evaluating immunosuppression in liver transplantation. However, ACR is not a major cause of graft loss, and a certain grade of immune activation...
LA  - en
PB  - Wiley
KW  - Acute cellular rejection
KW  - Liver biopsy
KW  - Liver transplantation
KW  - Randomized controlled trial
KW  - Transaminases
KW  - Biomarkers
KW  - Biopsy
KW  - Graft rejection
KW  - Graft survival
KW  - Humans
KW  - Immunosuppression therapy
KW  - Liver
KW  - Liver failure
KW  - Liver transplantation
KW  - Randomized controlled trials as topic
KW  - Treatment outcome
TI  - Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.
TY  - research article
VL  - 29
ER  -